curriculum vitae

Curriculum Vitae
Name
Gaetana Rinaldi
Address
Birthdate
Nationality
Language(s)
Italian
CURRICULUM STUDIORUM
o 1983: High School Degree by Istituto Magistrale ”P.Domina “ in Petralia
Sottana,.
o 1998: University degree in Medicine and Surgery by University of Palermo,.
 Thesis entitled “Importanza dell’ECP e della triptasi nella rinite
allergica“.
o 27/10/2004: Post-Graduate in Clinical Oncology, score 50/50 cum laude by
University of Palermo.
 Thesis entitled “Weekly docetaxel as second line therapy of NSCLC”
o 05/01/05: II Level Master in Supportive care by University of Palermo.
 Thesis entitles “Intestinal blockage”.
o 2007: Ph. D in “Molecular and cellular Oncopathology” by University of
Palermo.
 Thesis entitled “Molecular targets for new treatments in salivary gland
carcinomas”.

Qualification training
In the first session in 1998 by University of Palermo.
o 24/06/98: Entering the Albo dei Medici Chirurghi ed Odontoiatri – Province of
Palermo.

Fellowships
o 1999-2001: A-two-years fellowship in Optimization of the multidisciplinary
treatment of head-neck tumors by A.O. Villa Sofia – C.T.O., Plastic and
Maxillofacial Surgery division and contemporary attendance of the ambulatories
for diagnosis and treatment of melanoma and sarcoma.
o 1999: Fellowship in Optimization of the treatment of brain tumors, refused to
attend the aforementioned one.

Scientific Activity
2
o June 1998 – February 1999: Internship by Medical Oncology division –
University of Palermo.
o Since December 2003, following the internship by the Experimental
Oncology Department directed by Prof. Parmiani – I.N.T. in Milan –
researching on vaccines against melanoma and subsequent authorization
too use them (unique experience in Southern Italy).
o Nowadays, by the Medical Oncology Department directed by Prof. N.
Gebbia, caring of Head and Neck tumors, melanoma and brain tumors.
o The continuous and close cooperation with the Head&Neck unit directed by
Dr. Licitra and radiotherapy department directed by Prof. Olmi by I.N.T. in
Milan has granted a great experience in the treatment of rare tumors and
great dexterity in concomitant medications e management of toxicities.
o Caring of biological therapy in the treatment of salivary gland tumors and
vaccine therapy in melanoma.
o MIUR academic project (chief: Prof. G. Campisi) entitled “Osteonecrosis of
the jaw caused by biphosphonates: a cross and longitudinal study planning
secondary and tertiary prevention”. (Prog. N° ORPA06NT2F).
o From 01/10/2005 to 23/12/2005: Attendance by Istituto Nazionale dei
Tumori in Milan for the project “Clinical and traslational research for tailored
organ sparing treatments in head & neck cancer patients “.

Teaching activity
o Since 2005: Lecturer in Master in Supportive Cares by University of
Palermo.
o 2007:
Lecturer
in
the
supplementary
subject
“Osteonecrosis
by
biphosphonates” in first degree courses of Medicine and Surgery, Dentistry
and Dental Hygiene.
o 2007: Cooperation with Prof. Gebbia in the lectures given to Radiotherapists
in training.
o Since 2006: Main lecturer training physician and nurses by O.N.L.U.S.
“S.A.M.O.” caring the terminally ill and best supportive care.
3
o From 12/02/2008 to 12/07/2008: qualification as tutor in post-graduate
course in Clinical Oncology.
o June 2007: Lecturer in the course “Supportive cares and management of
toxicity by chemiotherapics” by University of Palermo.
o November 2007: Lecturer in the course “Medication in Oncology big killers”
“ by Ospedale S.Giovanni di Dio in Agrigento.
o March 2008: Lecturer in the course “Update on breast cancer“ by University
of Palermo.
o May 2008: Lecturer in the congress “Obiettivo salute” in Santo Stefano di
Camastra.
o December 2008: Lecturer in the local health district of Palermo training
project entitled “The old patient: issues and solutions”.
o May 2009: Lecturer in the course “Recent acquisitions of knowledge in
Hematology and Geriatric Oncology” in Termini Imerese.
o May 2009: Lecturer in the congress “Supportive care in therapy, resorts and
management” in Marinella di Selinunte.
o October 2009: Organization of the course “Tumors of the oral cavity:
diagnostic and therapeutic pathways”.
o March 2010: Lecturer in the update course “Clinical practice and guidelines”
by University of Palermo.
o April 2010: Lecturer in the III regional congress on Supportive Care (SICP)
in Palermo.

Clinical activity
o From June 1998 to 2001: Internship in Medical Oncology by University of
Palermo.
o From February to November 2003: Internship as oncologist in training by
I.N.T. in Milan in oral and maxillofacial surgery division directed by Dr. G.
Cantù.
o From February to November 2003: Internship as oncologist in training by
I.N.T. in Milan in head & neck tumor surgery directed by Dr. L. Licitra.
4
o From September to October 2003: Internship as oncologist in training by
I.N.T. in Milan in Supportive Care division directed by Dr. F. De Conno.
o Since January 2004 in charge as Oncologist of the multidisciplinary
ambulatory of head & neck tumors and melanoma by Plastic Surgery
division.
o Since January 2004 in charge of the men division in the Medical Oncology
department.
o Since 2008 teaching fellow by University of Palermo – Department of
Oncology.
o Since 2000 in charge for training physicians and nurses in supportive care
for O.N.L.U.S. “S.A.M.O.”
o Since January 2010 member of the S.A.M.O. board of directors as Main
Health Manager.
5

ABSTRACTs
1. Musciotto A.,Rinaldi G.,Lo Casto A., Campisi G. “ Esposizione spontanea di osso
necrotico mandibolare in assenza di segni Rx-Opt in paziente in terapia con acido
zoledronico per carcinoma renale e metastasi osse” – Osteonecrosi dei
mascellari:prevenzione,diagnosi,trattamento – Update 2009 ,Alessandria -23
giugno 2009
2. A.Intravaia , G.Bellavia , ML Traina, G.Alaimo, G.Miceli,G Di Silvestri, G.D’Alia,
G.Oddo, G.Rinaldi “ Un’assistenza difficile “ - XV Congresso Nazionale Società
Italiana di Cure Palliative, Giardini Naxos 3-6 Novembre 2008.
3. G.Polizzi , G.Bellavia , D.Patti , A Intravaia , ML Cutrera , G.Oddo , G.Rinaldi “Lo
sguardo del testimone “ - XV Congresso Nazionale Società Italiana di Cure
Palliative, Giardini Naxos 3-6 Novembre 2008.
4. ML Traina , DN Girelli , G Polizzi , D Renda , S.Virgilio , G. Cardinale , G. Miceli ,
G. Oddo , G. Rinaldi “ Come usiamo il tempo “ - XV Congresso Nazionale Società
Italiana di Cure Palliative, Giardini Naxos 3-6 Novembre 2008.
5. G.Bellavia , V Brucato , G Polizzi , ML Traina , DN Girelli , S Virgilio , A Caruselli ,
F Guccione , V Costanzo , G. Rinaldi “ Stress del caregiver nel paziente
oncologico terminale “-XV Congresso Nazionale Società Italiana di Cure Palliative,
Giardini Naxos 3-6 Novembre 2008.
6. G. Bellavia , G Polizzi , G Alaimo , G Dalia , G Di Silvestre , R Garofalo , G Miceli ,
G. Rinaldi “ Cure palliative domiciliari nel paziente oncologico terminale” - XV
Congresso Nazionale Società Italiana di Cure Palliative, Giardini Naxos 3-6
Novembre 2008
7. M.Brandi
,G.Badalamenti,F.Sorrentino,L.Vizzini,L.Incorvaia,G.Rinaldi,
M.
Sanfilippo , N.Gebbia , C.Intrivici, G.Caruso.”Contrast – enhanced
ultrasonography(CEUS) in retroperitoneal liposarcomas. JCO,2007 ASCO PartI
Vol 25 No 18s(June 20 Supplement)2007 :20514
8. V. Agnese, S. Corsale, L. Bruno, C. Augello, G. Gargano, V. Schiro’, L. la Paglia,
D. calcara, M. terrasi, F. Barbera, V. Gregorio, E. Foddai, C. Intrivici, G. Rinaldi ,
S. Cascio, E. Srmacz, N. gebbia and V. Bazan and A. Russo “BRCA1 mutation
analysis in breast and ovarian cancer famiglie from southern Italy (Sicily) and
avidence of founder effect Oral session – 18th International Congress on Anti
Cancer treatment Pris, February6-9,2007.
9. L.F.Licitra,LD Locati, P. Potepan, F. Crippa, P. Bossi, C. Bergamini, G. Rinaldi , C.
Liberatoscioli, F. Perrone,M.Losa,S.Pilotti” Cetuximab (C225) in recurrent and/or
metastatic salivary gland carcinomas(RMSGCs): a monoistitutional phase II study”
– ASCO 2006 Abstract No 5547
6
10. M.R. Valerio, F. Fulfaro, G. Cicero, G. Rinaldi, O. Maiorana, F. Spinnato, C.
Intrivici ,A.Crosta,C.Scibilia,T.Pizzo,P.Vanella § N.Gebbia “ Weekly paclitaxel and
pegylate liposomal doxorubicina(PLD) as first-line therapy in metastatic breast
cancer” 8th National GOIM Caongress 18-21 june 2006,Messina Annals of
Oncology Vol 17,2006 Supplement.
11. S. Corsale, V. Agnese, C. Augello, L. Bruno, D. Calcara, V. Calo’, G. Gargano, V.
Gregorio, A. Gullo, L. La Paglia, V. Schiro’, M. Terrasi, A. Crosta, G.Rinaldi, R.M.
Tomasino,V.Morello,E.Daniele,G.Pantuso,E.fiorentino,A.Chiarini,A
Martorana
,V.Bazan and A Russo” TP53 mutation and micro satellite instability are prognostic
factors in gastric cancer?”.8th National GOIM Congress 18-21 June 2006,Messina
– Annals of Oncology Vol 17,2006 Supplement 7.
12. S. Corsale, V. Agnese, C. Augello, L. Bruno, D. Calcara, V. Calo’, G. Gargano, V.
Gregorio, A. Gullo, La Paglia, V. Schiro’, M. Terrasi, G.Rinaldi, A. Crosta,
G.Badalamenti,R.M.Tomasino,V.Morello,E.Daniele,A.Gerbino,M.Buscemi,G.A.Chia
rini,A.Martorana,V.Bazan § A.Russo “ P16 INK4A ,P53 alterations and S phase
fraction are predictive of clinical out come in laringeal aquamous cell carcinoma.
8th National GOIM Congress 18-21 June 2006 , Messina – Annals of Oncology Vol
17,2006 Supplement 17.
13. C. Arcara, G. Badalamenti, G. Rinaldi, A. Crosta , M.G. Travagliato, O. Maiorana,
A. Cocchiara “A Case of squamocellular penile carcinoma with elevated basal
levels of ferritin : relationship between clinical and serologic response “ . 20 th
National GOIM Congress 13-16 June 2005 ,Bari – Annals of Clinical Oncology Vol 16 ,2005 Suppl. 4.
14. L.D.Locati,P.Bossi,G.Rinaldi , C.Bergamini, P.Quattrone, S.Staurengo, S.Pilotti,
L.Licitra.” Anti-androgen therapy in recurrent and/or metastatic salivary glands
carcinoma (RSGC) .3rd Intenational Symposium on Targeted Anticancer Therapies
;TAT 2005 Amsterdam March3-5,2005 .
15. M.R. Valerio, G. Rinaldi, G. Badalamenti, C. Arcara, G. Cicero, C. Sortino, F.
Spinnato, O.Maiorana,A.Cocchiara ,A.Russo, G.Gulotta, N.Gebbia, F.Fulfaro “ A
phase 2 study of oxaliplatin(O )-capecitabine (C) chemotherapy in metastaic breast
cancer (MBC) patients pretreated with anthracyclines and taxanes “ – 6th National
Congress of Medical Oncology 21-24September,2004:Bologna,Italy
16. M.R. Valerio, G. Rinaldi, G. Badalamenti, C. Arcara, G. Cicero, C. Sortino, F.
Spinnato, O.Maiorana,A.Cocchiara ,A.Russo, G.Gulotta, N.Gebbia, F.Fulfaro “ A
phase 2 study of oxaliplatin(O )-capecitabine (C) chemotherapy in metastaic breast
cancer (MBC) patients pretreated with anthracyclines and taxanes “ – 40th Annual
meeting (ASCO ) june 5-8,2004 New Orleans – Supplement to Journal of Clinical
Oncology Vol. 22 No 14s.
17. E.tamborini,
T.Negri,G.Dagrada,
L.D.locati
,
M.Guzzzo,
L.Licitra,
P.Bossi,G.Rinaldi , G.Cantu’ , M.A.Pierotti ,and S.Pilotti “ HER2 expression and
gene amplification in salivary duct cancer (SDC).AACR – NCI- EORTC
International Conference November17-21,Boston.
7
18. L.D.Locati, M.Mela, P.Quattrone, P.Bossi, A.Biffi, G.Rinaldi ,A.Laffranchi
,G.Cantu’, S.Pilotti, L.Licitra “ Anti-androgentherapy in recurrent and/or metastatic
salivary glands carcinoma (RSGC) – 5th National Congress of Medical Oncology
21-24October,2003 Rome. Annals of Oncology vol.14,2003 Supplement 4.
19. G.Rinaldi,L.Licitra,M.Squadrelli,M.Guzzo,C.Fallai,L.D.Locati,P.Bossi,G.cantu’,P.Ol
mi “ Comparative review of internet –available guidelines on oropharyngeal and
oral cavity cancer” : 5Th National Congress of medical Oncology 21-25October :
Rome ; Annals of Oncology Vol 14,2003 Supplement 4.
20. P.Bossi, M.Squadrelli, M.Oggionni, S.Suardi, L.D.Locati,A.Biffi, G.Rinaldi ,
G.Cantu’, S.Pilotti, L.Licitra “ Prognostic relevance of HPV and TP53 gene status in
squamous cell cancer (SCC) of oropharynx treated with surgery+/- radiotherapy
(TR) “ ; 5th National Congresso f Medical Oncology 21-24October,2003 Rome .Annals of Oncology Vol 14,2003 Supplement 4.
21. C. Arcara, S. Siragusa, E. Bajardi, M.G. Armata, F. Fulfaro, G. Badalamenti, M.R.
Valerio, G. Rinaldi , A.Russo, C.Intrivici, A.Russo, G.Mariani , P.Luparello,
F.Buscaglia,N.Gebbia “ D-Dimer levels and thrombosis : an observational study in
colorectal cancer patients treated with standard chemotherapy “ 5 th National
Congress of Medical Oncology 21-24October,2003 Rome - Annals of Oncology :
Vol.14 Supplement 4.
22. P.Bossi, M.Squadrelli, M.Oggioni, S.Suardi, L.D.locati, A.Biffi, G.Rinaldi , L.Licitra,
G.Cantu’, S.Pilotti. “ HPV infection as prognostic factor in sqamous cell carcinoma
cancers (SCC) of oropharynnx treated with surgery with or without radiotherapy
(RT). European Cancer Conference Copnhagen 21-25 september 2003 – EJC
supplements Vol I No 5.
23. G.Cicero, M.G.Armata, F.Fulfaro, E.Bajardi, G.Badalamenti, C.Arcara, G.Rinaldi
,A.Russo,N.Gebbia “ Weekly docetaxel in chemio-hormono-resistant prostate
cancer” ASCO 2003 May 31-June3,2003 Chicago – Vol 22 .
24. Valerio M.R., Fulfaro F,Badalamenti G, Aracra C,Cicero G., Rinaldi G. , Amato C.
, Fricano S,Vizzini L,Intrivici C,Travagliato L.,Russo A., Gebbia N. “ oxaliplatinCapecitabine combination chemo-therapy in metastatic breast cancer patients
pretreated with anthracyclines and taxanes. Journal of Tumaor Marker Oncology
Vol 18 Number 3 Summer 2003.
25. La Rocca G.,Cascio S,Migliavacca M,Bazan V.,Agnese V., Amato A.,Corsale
S,Calo’ V, Cammareri P.,Sisto PS,Totaro MS, Benfante B., Fulfaro F., Rinaldi G ,
Valerio MR, Vizzini L ,Florena A , Franco V, Di Fede G: ,Gebbia N, Russo A. “
Determination of the clonality of a lynphocyte population in the diagnosis of
lymphomas” - Journal of Tumaor Marker Oncology Vol 18 Number 3 Summer 2003.
26. MR Valerio,F.Fulfaro,G.Badalamenti,E.Bajardi,C.Arcara, G.Rinaldi ,A.Crosta ,
G.Cicero e N.Gebbia “ Efficacia dell’associazione Paclitaxel e doxorubicina
liposomiale come trattamento di prima linea nel carcinoma mammario metastatico”
8
– Paclitaxel present and future perspectives ; Napoli 21-22 marzo 2003 – Abstacts
Book
27. G.Rinaldi , E.Bajardi,MR Valerio , G.Badalamenti , C.Arcara, F.Fulfaro ,G.Cicero
,A.Crosta, A.Russo e N.Gebbia “ Utilizzo di IFN-alfa,IL2 ,Gemcitabina ,Ftorarur e
medrossiprogesterone acetato nel carcinoma renale metastatico (CRM). XV
Congresso Nazionale – Associazione Italiana di Immunofarmacologia –Catania 2830 novembre 2002.
28. C.Arcara,SerrettaV,Badalamenti G,Leto G,Fulfaro F, valerio MR , Armata M,
Bajardi E , Rinaldi G , Cicero G , Crosta A , Russo A e Gebbia N “ Uso dell’acido
zoledronico nel trattamento del dolore da metastasi ossea in pazienti con
carcinoma prosttico” – SIUrO XII Congresso Nazionale Società italiana di Urologia
Oncologica Firenze 20-22 Novembre 2002 .
29. Arcara C., Serretta V, Leto G ,Fulfaro F ,Valerio MR ,Bajardi E , Rinaldi G , Cicero
G , Badalamenti G , Crosta A , Russo A e Gebbia N “ Su di un caso di carcinoma
squamo cellulare del pene localmente avanzato con elevati valori basali di ferritina
sierica” - SIUrO XII Congresso Nazionale Società italiana di Urologia Oncologica
Firenze 20-22 Novembre 2002 .
30. F.Fulfaro , MR Valerio, E.Bajardi , G.Rinaldi , C.Arcara , G.Cicero , A.Crosta ,
G.Badalamenti , A.Russo , S.Guarino , A.serruto , R.Vassallo , C.Amato , B.Napoli,
S.Fricano , I.Zanna, MA Latteri and N. Gebbia “ Clinicophathological relationships
of endometrial lesions(EL) in breast cancer(BC) patients treated with adjuvant
tamoxifen “ 4th National Congresso of medical Oncology 28 September-1
October,2002 : Turin – Annals of Oncology Volume 13,2002 Supplement 3.
31. MR Valerio, F.Fulfaro , E.Bajardi , G.Cicero , G.Badalamenti , C.Arcara , A.Crosta
, G.Rinaldi , MG Armata , G. Cucinella , G.Lampasona, G.Catalano, A.Martorana,
A.
Perino
,
Russo
A
,
N.Gebbia
“
Pegylate
liposomial
doxorubicin(PLD),oxaliplatin(O) and cyclophospamide(CTX) as second line therapy
in recurrent or platinum refractory ovarian cancer patients:a phase II study” - 4th
National Congresso of medical Oncology 28 September-1 October,2002 : Turin –
Annals of Oncology Volume 13,2002 Supplement 3.
32. S.Corsale , I.Zanna , M.Migliavacca , M.T.Sanz-Casia , M.L.Maestro ,V.Bazan ,
C.Tubiolo ,A.Amato , V.Calo ’, P.Cammareri , MR Valerio, R.Gargano , R.di Leo
,S.Restivo ,P.L.Quintela ,R.Bernaldez , A.Crosta , G.Badalamenti , G.Rinaldi , MR
Tomasino ,N.Gebbia ,and A.Russo “ P16 INK4A mutations are independent prognostic
factors in lically advanced laringea squamous cell carcinoma”. 4th National
Congresso of medical Oncology 28 September-1 October,2002 : Turin – Annals of
Oncology Volume 13,2002 Supplement 3.
33. F.Fulfaro , MR Valerio , E.Bajardi , G.Rinaldi , C.Arcara , G.cicero , A.Crosta ,
G.Badalamenti,A.Russo,S.Guarino,A.Serruto,R.Vassallo,C.Amato,B.Napoli,S.Frica
no,M.Migliavacca,MA Latteri and N.Gebbia “ Correlazioni clinico patologiche delle
lesioni endometri ali in pazienti con carcinoma della mammella trattate con
tamoxifen “ – Qualità della Vita e Controllo dei Sintomi – Siracusa 6 Luglio 2002.
9
34. Valerio MR, Bajardi E., Fulfaro F.,Verderame F, Cicero G., Arcara C. , Rinaldi G.,
Crosta A., Russo A., and Gebbia N. “ Taxotere settimanale come terapia di
seconda linea nel tumore polmonare non a piccole cellule già trattato con
cisplatino” – 6° Congresso Nazionale GOIM Napoli 11-15 giugno 2002 Volume
degli atti.
35. MR Valerio, F. Fulfaro, E. Bajardi, G. Cicero, MG Armata, G. Badalamenti, C.
Arcara, A. Crosta, T. Rinaldi, N. Gebbia, G. Cucinella, G. Lampasona, G.
Catalano, A. Martorana, A. Perino, A. Russo “ Doxorubicina in liposoma
pegilato,oxaliplatino e ciclofosfamide nella terapia di seconda linea del carcinoma
ovarico”- 6° Congresso Nazionale GOIM Napoli 11-15 giugno 2002 Volume degli
atti.
36. MR Valerio, F.Fulfaro, M.Brandi, E.Bajardi, G.Cicero, G.Badalamenti, C.Arcara,
A.Crosta,T.Rinaldi ,N. Gebbia , G.Cucinella, G.lampasona, G.Catalano ,
A.Martorana , A.Perino,A.Russo, “ A phase II study of pegylated doxorubicina
,oxaliplatin and cyclophashamide as second line therapy in recurrent or platinum
refractory ovarian cancer patients” ASCO May 18-21 ,2002 Orlando – Volume 21,
Part 1 of 2.
37. M.R.Valerio,F.fulfaro,G.cicero,G.Badalamenti,E.Bajardi,C.Arcara,A.Crosta,T.Rinal
di,N.Gebbia,G.Cucinella,G.lampasona,G.Catalano,A.Martorana,A.Perino,A.Russo:
A phase II study of pegylated doxorubicina ,oxaliplatin and cyclophashamide as
second line therapy in recurrent or platinum refractory ovarian cancer patients” –
Twelfth International Congress on Anti –Cancer Treatment ; February 4TH -7TH
,2002 –Paris
38. A.Russo,MR Valerio, E.Bajardi , C.Arcara , G.Badalamenti , A.Crosta , S.Morini ,
G.Rinaldi , G.Pantuso , G.Graceffa , N.Grassi , G.Vetri , G.Di Gesu’ “ 5 FU
continuous infusion in the pretreated brest cancer “ – 11th International Congress
on Anti –Cancer Treatment ; 6-9 Fevrier 2001 Paris .

Original articles
1. Colella G, Cannavale R, Vicidomini A, Rinaldi G, Compilato D, Campisi G. Efficacy of
a spray compound containing a pool of collagen precursor synthetic aminoacids (lproline, l-leucine, l-lysine and glycine) combined with sodium hyaluronate to manage
chemo/radiotherapy-induced oral mucositis: preliminary data of an open trial. Int J
Immunopathol Pharmacol. 2010 Jan-Mar;23(1):143-51.
2. Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S,
Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V,
Bonizzoni E, Tonato M; PROTECHT Investigators. Nadroparin for the prevention of
thromboembolic events in ambulatory patients with metastatic or locally advanced
10
solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind
study. Lancet Oncol. 2009 Oct;10(10):943-9. Epub 2009 Aug 31.
3. Tomasino RM, Morello V, Gullo A, Pompei G, Agnese V, Russo A, Rinaldi G.;
Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may
be a helpful tool in management of patients with flat epithelial atypia (FEA) and
columnar cell lesions (CCLs) on core breast biopsy. J Cell Physiol. 2009
Nov;221(2):343-9.
4. Locati LD, Bossi P, Perrone F, Potepan P, Crippa F, Mariani L, Casieri P, Orsenigo M,
Losa M, Bergamini C, Liberatoscioli C, Quattrone P, Calderone RG, Rinaldi G, Pilotti
S, Licitra L.; Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A
phase II study. Oral Oncol. 2009 Jul;45(7):574-8. Epub 2008 Sep 18.
5. Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci
G, Bazan V, Russo A. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol.
2007 Jun;18 Suppl 6:vi93-8. Review
6. A.Russo,V.Calo’,V.Agnese,L.Bruno,S.Corsale,C.Augello,G.Gargano,F.Barbera,S.Casc
io,C.Intrivici,G.Rinaldi,G.Gulotta,M.Macaluso,E.Surmacz,A.Giordano,N.Gebbia,V.Baz
an. “BRCA1 genetic testing in 106 breast and ovarian cancer families from suthern
Italy (Sicily): a mutation analyses-Breast Cancer Res Treat DOI10.2007/s10549-0069456-9
7. C.DiLiberto,M.Caroprese,G.Pizzo,D.Compilato,F.Fulfaro,G.Rinaldi,L.LoMuzio,G.Camp
isi “Complicanze orali in pazienti affetti da carcinoma del cavo orale e sottoposti a
radio e chemioterapia.Mucositi e xerostomia”. Recenti Progressi in Medicina Vol.98,N5
Maggio 2007 pag.302-314.
8. P.Bossi,C.Liberatoscioli,C.Bergamini,L.D.Locati,S.Fava,G.Rinaldi,E.Orlandi,P.Olmi,E.
Tagliabue,S.Mènard e L.Licitra “ Previously irradiated areas spared from skin toxicity
induced by cetuximab in six patients : implications for the administration of EGFR
inhibitors in previously irradiated patients” Annals of Oncology october 30,2006.
9. G.Gargano , V.Agnese , V.Calo’ , S.Corsale , C.Augello , L.Bruno , L.La Paglia ,
A.Gullo , L.Ottini , A.Russo , F.Fulfaro , G.Rinaldi , A.Crosta , G.Cicero , O.Maiorana ,
L.Palmeri , C.Cipolla , A.Agrusa , G.Gulotta , V.Morello , G.Di Fede , V.Adamo ,
G.Colucci , R.M. Tomasino , M.R.Valerio , V.Bazan&A.Russo “Detection and
quantification of mammaglobin in the blood of breast cancer patients : can it be useful
as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico
dell’Italia Meridionale) prospective study “ Annali of Oncology 17 (Supplement 7)
:vii41-vii45,2006.
10. V.Bazan , L.Bruno , C.Augello , V.Agnese , V.Calo’ , S.Corsale , G.Gargano ,
M.Terrasi , V.Schiro’ , G.Di Fede , V.Adamo, C.Intrivici , A.Crosta , G.Rinaldi ,
F.Latteri , G.Dardanoni , N.Grassi , M.R.Valerio , G.Colucci , M.Macaluso & A.Russo “
Molecular detection of TP53 , KI RAS and p16 INK4Apromoter methylation in plasma of
patients with colorectal cancer and its association with prognosis.Results of a 3 – year
11
GOIM (Gruppo Oncologico dell’Italia Meridionale) prospective study . Annali of
Oncology 17 (Supplement 7): vii<84 – vii 90 , 2006.
11. V.Agnese , S.Corsale , V.Calo’ , C.Augello , L.Bruno , D.Calcara , A.Crosta ,
V.Rodolico , G.Rinaldi , G.Cicero , F.Latteri , A.Agrusa , V.Morello , V.adamo ,
G.Altavilla , G.Di Fede , E.Fiorentino , N.Grassi , M.A.Latteri , M.R.Valerio , R.M.
Tomasino , G. Colucci, V.Bazan & A. Russo “ Significance of P16 INK4A
hypermethylation gene in primary head/neck and colorectal tumors : it is a specific
tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell’Italia Meridionale)
prospective study” . Annali of Oncology 17 (Supplement 7) : vii 137 – vii 141,2006.
12. C.Augello , V.Gregorio, V.Bazan , P.Cammareri , V.Agnese , S.Cascio , S.Corsale ,
V.Calo’, A.Gullo, R.Passantino , G.Gargano , L.Bruno, G.Rinaldi , V.Morello ,
A.Gerbino , R.M.Tomasino , M.Macaluso , E.Surmacz , and A.Russo.”Tp53 and
P16INK4A , but not H – KI – RAS , are involved in tumorigenesis and progression of
pleomorfic adenomas”. Journal of cellular physiology 9999:1-6 (2005)
13. L.D. Locati , G. Rinaldi , P. Bossi , L. Licitra , G.P. Dagrada , P. Quattrone G. Cantu’
“Herceptin plus chemotherapy in relapsed and/ or metastatic salivary gland cancer“.
Oral oncology ( 2005 ) 41, 97-98.
14. F.Fulfaro , G.Badalamenti , E.Bajardi , M.R.Valerio , C.Arcara , G.Cicero , A.Russo ,
G.Rinaldi , C.Intrivici , L.Vizzini e N. Gebbia “ Utilizzo dei farmaci adiuvanti nel dolore
da cancro Review“ Oncologia ed ematologie moderne n1Aprile 2005 pag 48 - 55
15. F.Fulfaro , E.Bajardi , G.Badalamenti , M.R.Valerio , G.Cicero , C.Arcara , G.Rinaldi ,
L.Vizzini , C.Intrivici , M.A.Latteri e N.Gebbia “ La terapia adiuvante nel carcinoma del
colon :un update della letteratura “.Oncologia ed Ematologia Moderne , 6(2) .Pag.54 –
62 2004
16. F.Fulfaro , S.Siragusa , C.Arcara , G.Badalamenti , M.R.Valerio, E.Bajardi , G.Cicero ,
G.Rinaldi , A.Crosta , G.Rotolo , M.Mariani , N.Gebbia.“Trombosi e cancro : principi di
profilassi e terapia “. Oncologia ed Ematologie Moderne , 5 (1).Pag 31-40 .2003
17. L.Licitra , G.Rinaldi “ Terapia di seconda linea nei tumori testa e collo .Pro. I
supplementi di Tumori vol.2 , n 4 , s65 . 2003
18. M.Migliavacca , V.Bazan , S.Corsale , A.Amato , V.Agnese , V.Calo’ , P.Cammareri,
S.Casio , G.La Rocca , P.S. Sisto , M.S. Totano , G.Badalamenti , A.Crosta , F.Fulfaro,
G.Rinaldi , M.R.Valerio , G.Di Fede , A.Russo. “ Clinical implication of genetic in
hereditary brest carcinomas “Acta Chirurgica Mediterranea .Vol. 19 , N.1, Pag. 5-9
.2003.
19. F.Fulfaro , M.R.Valerio , N.Faldetta , E.Bajardi , M.G.Armata , G.Cicero ,
G.badalamenti, C.Arcara , G.Rinaldi , A.Crosta , N.Gebbia , G.B.Rini “Utilizzo
dell’Acido Zoledronico nella malattia osse metastatica “ .Oncologia ed Ematologia
Moderne , 4(2) . Pag 9-17, 2002.
12

Congresses

15 April 2000 : Chemioterapia antiblastica orale e qualità di vita –Palermo

4 May 2000 : le lesioni cutanee nel terzo millennio – Palermo

24 June 2000: Carcinoma della mammella : una realtà in evoluzione –
Palermo.

10 November 2000 : Indicazioni di follow up e trattamento nel melanoma
cutaneo – Messina.

April 17-22 2001 : advances in oncology : current perpsectives on
biomolecular indicators end clinical management of bludder , brest ,colon
rectal and lung cancers – erice.

10 October 2001 : Nuovi approcci nella patologia neoplastica della prostate
: dalla ricerca alla clinica – Palermo.

10 November 2001 : Il carcinoma del colon retto – Agrigento.

1 December 2001 : Capecitabina : aspetti terapeutici attuali e futuri –
Palermo .

15 December 2001 : Attualità nella terapia medica del carcinoma colon
rettale – palermo

19 December 2001 : Convegno Nazionale : Il trattamento del carcinoma
vescicale – Roma .

5 January 2002 : Attualità in oncologia – S. stefano di Calastra ( Me).

19 January 2002 : Aggiornamenti in oncologia: hospice ospedaliero –
Modica (Rg).

27-29 January 2002 : i tumori della mammella nella paziente anziana –
Bologna.

8-9 March 2002 : Meet de professor 2002 – Rozzano (Mi).

28 September – 1 October 2002 : AIOM Congresso nazionale di oncologia
medica – Torino

9 November 2002 : Il dolore oncologico : nuovi approcci clinico terapeutici –
Palermo.

18 Novembre 2002 : up date sul trattamento dei tumori polmonari – Milano.
13

14-15 May 2003 : corso di aggiornamento sulla patologia tumorale della
tiroide – Milano

16 May 2003 : Il carcinoma gastrico : la terapia adiuvante – Milano.

13-15 October 2003 : I sarcomi dei tessuti molli dell’adulto – Milano.

21-24 October 2003 : V congresso nazionale AIOM .

27-28 October 2003 : Dolore – Cure palliative – Eutanasia : risposte ed
attese della medicina verso la spiritualità – Milano.

12 December 2003 : Corso di aggiornamento sulle antracicline – Bari

30-31 January 2004 : convivium : nuove conoscenze sul dolore oncologico
ed implicazioni cliniche nella terapia con oppioide – Roma

21 February 2004 : carcinoma del colon retto : dallo screening alla terapia .

28 February 2004 : corso di aggiornamento sulle antracicline –palermo

14 May 2004 : tumori neuroendocrini : evoluzione delle conoscenze _
Milano

23 June 2004 : th investigators meeting studio myocet l017 “ phase II study
of liposomal doxorubicin( myocet) , docetaxel and trastuzumab as first –line
treatment of pazients with Her 2/ neu positive localy advanced or metastatic
breast cancer”.- Roma

9 September 2004 : metastasi cerebrali : importanza dell’approccio
interdisciplinare – Palermo.

13 October 2004 : Il cancro del colon retto – Palermo

11-12 March 2005 : 3 rd international conference on future trends in
threatment of brain tumors – Padova

21 May 2005 : attualità in chirurgia mininvasiva – Mistretta

6 June 2005 : investigators meeting sui protocolli nazionali dei tumori della
testa e del collo – Milano

20 May 2006 : L’utilità della terapia adiuvante ormonale nelle fasi precoci
del tumore della mammella – Palermo

29-30 September 2006 : Il dolore oncologico : come affrontarlo – Palermo

12-13 October 2006 : Simposio su targeted terapy nei tumori testa –collo :
consensus conference per la terapia del carcin oma laringeo – Milano
14

20 October 2006 : carcinoma polmonare e terapie biologiche : progressi e
prospettive – Genova

30-31 October 2006 : 1 St mediterranean forum of neuro oncology – Napoli

30 November - 2 December 2006 : 12 th annual meeting italian melanoma
intergroup – Bari

17 April 2007 : international consensus experts panel “ second line
treatment of advanced non small cell lung cancer “ – Napoli

11 May 2007 : 16 riunione nazionale gruppo ITMO “ melanoma : ricerca
,diagnosi , trattamento” – Milano

22 June 2007 : workshop on GIST – appropiatezza clinica e integrazione
nei processi di cura “ – Palermo

27-28 September 2007 : master corse “ management del pazient con
melanoma “ – palermo

12 -15 October 2007 : 9 congresso nazionale di oncologia medica ( AIOM )
– Palermo

19 October 2007 : corso su carcinoma del capo e del collo : ruolo della
chemioterapia e delle terapie biologiche del trattamento delle neoplasie in
operabili – Mestre ( VE) .

29-31 October 2007 : 13 th annual meeting of the italian melanoma
intergroup “ melanoma present and future “ – Padova

22 November 2007 : Terapie biologiche nel non small cell lung cancer –
Napoli

23-24 November 2007 : mediterranean school of oncology : kidney cancer
and melanoma : progressess in clinical and traslational research - Roma

12 December 2007 : I tumori neuroendocrini e la pratica clinica – Palermo .

17-18 December 2007 : Grandangolo 2007 . Un anno di oncologia ( nona
edizione ) – Genova

22-23 February 2008 : IV international conference on future trends in
treatment of brain tumors – Bologna

4—5 April 2008 : percorso terapeutico nel carcinoma polmonare ( NSSCL)
– Palermo
15

10-11 April 2008 : advanced haed and neck tumors : new trends in medical
and radiotherapy modalities – Milano

18 -19 April 2008 Caratterizzazione biologica e terapia dei tumori solidi :
carcinoma mammario e carcinoma polmonare – Taormina .

23-24 May 2008 : secondo convegno Obiettivo salute – S. Stefano di
Camastra ( ME)

26-28 June 2008 : Prima conferenza italiana di oncologia toracica – Napoli

6-7 October 2008 : IFHNOS global continuing educational programm :
current concept in head e neck surgery and oncology – Roma

7-8 November 2008 : Mediterranean school of oncology : highlights in
management of kidney cancer – Roma

13-15 November 2008 : 14 congresso annuale intergroup melanoma
italiano – Roma

23 January 2009 : I GIST : l’importanza della multidisciplinareità – Palermo

27-28 March 2009 : progressi nella terapia dei tumori solidi – palermo

29 May – 2 June 2009 : American Society of Clinical Oncology (ASCO) –
Orlando (USA).

18-20 October 2009 : 15 congresso annuale intergroup melanoma italiano –
Genova .

3-6 March 2010 : IV EHNS european conference on head and neck
oncology – Atene

27-29 April 2010 : Gestione del paziente oncologiuco : up date su diagnosi
etrattamento in alcune patologie neoplastiche.

10 May 2010 : aggiornamenti in oncologia : nuove strategie terapeutiche e
targets terapy nel carcinoma della mammella” – Palermo.

December 2010 : moderatrice del corso nazionale , tenutosi a Palermo,
NIBIT.

Congresses as lecturer
16

30 May – 1 June 2005 : V congresso nazionale della società italiana di
endoscopia – Palermo

27-28 June 2007 : la terapia di supporto e gestione della tossicità da
chemioterapia – palermo

19 September 2007 : up date in oncologia – Palermo

30 November – 1 December 2007 : la terapia medica dei “big killers” in
oncologia – up date 2007.

28 March 2008 : up date on breast cancer – palermo

31 January 2009 : Corso su recenti acquisizioni in ematologia ed oncologia
geriatrica – Termini Imerese (PA).

9 May 2009 : corso su recenti acquisizioni in ematologia ed oncologia
geriatria – Termini imprese (PA).

15-16 May 2009 : cure palliative tra terapia ,risorse e management –
Marinella di Selinunte (TP)

23 -24 October 2009 : Organizzatior e relatore del Corso su I tumori del
cavo orale : percorsi diagnostici e terapeutici – Palermo.

31 October 2009 : opinioni a confronto sul tumore polmonare : corso
interattivo – Castelvetrano (TP).

10 March 2010 : corso di aggiornamento “ pratica clinica e linee guida” –
Palermo.

10 May 2010 : Aggiornamenti in Oncologia : nuove strategie terapeutiche e
target therapy nel carcinoma della mammella – Palermo

25 June 2010 : “ToGeErb – La nuova opzione terapeutica nel carcinoma
mammario Erb2+” – Palermo.
La sottoscritta esprime il proprio consenso affinchè i dati personali possano essere
trattati, nel rispetto della legge n. 196/2003, per gli adempimenti connessi al
presente concorso.
17
Palermo,
Firma________________________________
18